BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 36244579)

  • 21. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.
    González-Yanes C; Sánchez-Margalet V
    Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromogranin-B regulation of IAPP and insulin secretion.
    Karlsson E; Stridsberg M; Sandler S
    Regul Pept; 2000 Feb; 87(1-3):33-9. PubMed ID: 10710286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.
    Lloyd RV; Jin L; Qian X; Scheithauer BW; Young WF; Davis DH
    Am J Pathol; 1995 May; 146(5):1188-98. PubMed ID: 7747813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of pancreastatin release from a human pancreatic carcinoid cell line in vitro.
    Jeng YJ; Townsend CM; Nagasawa S; Chuo S; Kern K; Yanaihara N; Ferrar RS; Hill FL; Thompson JC; Greeley GH
    Endocrinology; 1991 Jan; 128(1):220-5. PubMed ID: 1702700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease.
    Watanabe T
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cells.
    Cetin Y; Aunis D; Bader MF; Galindo E; Jörns A; Bargsten G; Grube D
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2360-4. PubMed ID: 8096340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pancreastatin secretion stimulation in healthy volunteers].
    Zagórowicz E; Bak M; Siemińska J; Muszyński J
    Pol Arch Med Wewn; 2002 Dec; 108(6):1185-91. PubMed ID: 12687931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
    Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
    Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.
    Watkinson A; Jönsson AC; Davison M; Young J; Lee CM; Moore S; Dockray GJ
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):471-9. PubMed ID: 1710890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture.
    Fasciotto BH; Gorr SU; DeFranco DJ; Levine MA; Cohn DV
    Endocrinology; 1989 Sep; 125(3):1617-22. PubMed ID: 2759035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis.
    Gayen JR; Saberi M; Schenk S; Biswas N; Vaingankar SM; Cheung WW; Najjar SM; O'Connor DT; Bandyopadhyay G; Mahata SK
    J Biol Chem; 2009 Oct; 284(42):28498-509. PubMed ID: 19706599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.
    Heaney AP; Curry WJ; Pogue KM; Armstrong VL; Mirakhur M; Sheridan B; Johnston CF; Buchanan KD; Atkinson AB
    Pituitary; 2000 Oct; 3(2):67-75. PubMed ID: 11141698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.
    Syversen U; Jacobsen MB; O'Connor DT; Rønning K; Waldum HL
    Neuropeptides; 1994 Mar; 26(3):201-6. PubMed ID: 8208366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical Localization of Chromostatin and Pancreastatin, Chromogranin A-Derived Bioactive Peptides, in Normal and Neoplastic Neuroendocrine Tissues.
    Kimura N; Funakoshi A; Aunis D; Tateishi K; Miura W; Nagura H
    Endocr Pathol; 1995; 6(1):35-43. PubMed ID: 12114688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA.
    Helman LJ; Ahn TG; Levine MA; Allison A; Cohen PS; Cooper MJ; Cohn DV; Israel MA
    J Biol Chem; 1988 Aug; 263(23):11559-63. PubMed ID: 3403545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the chromogranin A-derived peptides pancreastatin and WE14 in rat stomach ECL cells.
    Norlén P; Curry WJ; Chen D; Zhao CM; Johnston CF; Håkanson R
    Regul Pept; 1997 Jun; 70(2-3):121-33. PubMed ID: 9272624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity.
    Bandyopadhyay GK; Mahata SK
    Front Endocrinol (Lausanne); 2017; 8():20. PubMed ID: 28228748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reserpine-induced processing of chromogranin A in cultured bovine adrenal chromaffin cells.
    Watkinson A; Robinson I
    J Neurochem; 1992 Mar; 58(3):877-83. PubMed ID: 1737996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution and partial characterisation of immunoreactivity to the putative C-terminus of rat pancreastatin.
    Curry WJ; Johnston CF; Shaw C; Buchanan KD
    Regul Pept; 1990 Oct; 30(3):207-19. PubMed ID: 2259750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides.
    Muntjewerff EM; Tang K; Lutter L; Christoffersson G; Nicolasen MJT; Gao H; Katkar GD; Das S; Ter Beest M; Ying W; Ghosh P; El Aidy S; Oldenburg B; van den Bogaart G; Mahata SK
    Acta Physiol (Oxf); 2021 Jun; 232(2):e13655. PubMed ID: 33783968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.